DiagnosticsNews

Sai Life Sciences to expand biology capabilities at its R&D campus

The new facility will house expanded in vitro and in vivo biology services, DMPK and toxicology capabilities

Sai Life Sciences, a contract research, development and manufacturing organisations, announced plans to significantly expand its biology capabilities at its integrated R&D campus in Hyderabad, India with a dedicated 75,000 sq ft facility and an augmented team of 170 biologists. The new facility will house expanded in vitro and in vivo biology services, DMPK and toxicology capabilities with the first set of labs scheduled to open in March 2021.

THIS CAN BE YOUR ADVERTISEMENT

Making the announcement, CEO and Managing Director of Sai Life Sciences, Krishna Kanumuri said, “We aspire to deliver over 100 development candidates for our innovator partners by 2025. Our growing discovery biology team co-located with our teams in medicinal chemistry, process development, process engineering and scale-up will enable us to accelerate our clients’ discovery programs through rapid turnaround times and shorter decision-making cycles.”

Last year, the company opened its first international R&D facility with a biology lab in Boston, USA. The Boston Biology Lab is designed to offer start-up and biotech companies in the region biology services to address exploratory and custom biology needs. The expanding team of biologists, DMPK & toxicology scientists in India works seamlessly with the Boston team to present clients an optimal solution in terms of speed, cost and talent.

 

 

Support us in our endeavor to bring you Advertisement free content.
Choose your options to donate or subscribe.

Tags

Related Articles

Leave a Reply

Back to top button
Close
Close